» Articles » PMID: 38951480

Can Probiotics Be Used in the Prevention and Treatment of Bronchial Asthma?

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2024 Jul 1
PMID 38951480
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a lifelong condition with varying degrees of severity and susceptibility to symptom control. Recent studies have examined the effects of individual genus, species, and strains of probiotic microorganisms on the course of asthma. The present review aims to provide an overview of current knowledge on the use of probiotic microorganisms, mainly bacteria of the genus Lactobacillus and Bifidobacterium, in asthma prevention and treatment. Recent data from clinical trials and mouse models of allergic asthma indicate that probiotics have therapeutic potential in this condition. Animal studies indicate that probiotic microorganisms demonstrate anti-inflammatory activity, attenuate airway hyperresponsiveness (AHR), and reduce airway mucus secretion. A randomized, double-blind, placebo-controlled human trials found that combining multi-strain probiotics with prebiotics yielded promising outcomes in the treatment of clinical manifestations of asthma. It appears that probiotic supplementation is safe and significantly reduces the frequency of asthma exacerbations, as well as improved forced expiratory volume and peak expiratory flow parameters, and greater attenuation of inflammation. Due to the small number of available clinical trials, and the use of a wide range of probiotic microorganisms and assessment methods, it is not possible to draw clear conclusions regarding the use of probiotics as asthma treatments.

Citing Articles

The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.

Guaman L, Carrera-Pacheco S, Zuniga-Miranda J, Teran E, Erazo C, Barba-Ostria C Nutrients. 2024; 16(21).

PMID: 39519539 PMC: 11547800. DOI: 10.3390/nu16213706.


Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm.

Tufail M, Schmitz R Probiotics Antimicrob Proteins. 2024; .

PMID: 39377977 DOI: 10.1007/s12602-024-10370-9.

References
1.
Wang Z, Li Y, Gao Y, Fu Y, Lin J, Lei X . Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respir Res. 2023; 24(1):169. PMC: 10288698. DOI: 10.1186/s12931-023-02475-6. View

2.
Ye L, Pan J, Pasha M, Shen X, DSouza S, Fung I . Mucosal-associated invariant T cells restrict allergic airway inflammation. J Allergy Clin Immunol. 2019; 145(5):1469-1473.e4. PMC: 7214121. DOI: 10.1016/j.jaci.2019.12.891. View

3.
Ye L, Pan J, Liang M, Pasha M, Shen X, DSouza S . A critical role for c-Myc in group 2 innate lymphoid cell activation. Allergy. 2019; 75(4):841-852. PMC: 7176544. DOI: 10.1111/all.14149. View

4.
Murrison L, Brandt E, Biagini Myers J, Khurana Hershey G . Environmental exposures and mechanisms in allergy and asthma development. J Clin Invest. 2019; 129(4):1504-1515. PMC: 6436881. DOI: 10.1172/JCI124612. View

5.
Barcik W, Boutin R, Sokolowska M, Finlay B . The Role of Lung and Gut Microbiota in the Pathology of Asthma. Immunity. 2020; 52(2):241-255. PMC: 7128389. DOI: 10.1016/j.immuni.2020.01.007. View